← Back to Search

Yoga for Young Adults with Cancer

N/A
Recruiting
Research Sponsored by University of Calgary
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Diagnosed with cancer between the ages of 18-39 years
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 5 years
Awards & highlights

Study Summary

This trial will explore whether a yoga program can help young adults affected by cancer in terms of physical and psychological outcomes, and how easy it is to implement the program.

Who is the study for?
This trial is for young adults aged 18-39 who have been diagnosed with cancer, are at any stage of treatment or recovery, and can safely do yoga. Participants must be able to understand and complete consent forms, questionnaires, physical assessments, and an interview in English.Check my eligibility
What is being tested?
The study is testing a specially developed yoga program designed to improve the physical and psychological well-being of young adults with cancer. This single-group study will assess the effectiveness of the program through various methods including participant feedback.See study design
What are the potential side effects?
Yoga is generally considered safe but may include side effects like muscle soreness or strain. The risk of more serious side effects is low if participants get medical clearance beforehand as required by this trial.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I was diagnosed with cancer between 18 and 39 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 5 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Reach
Secondary outcome measures
Adherence
Adverse events
Aerobic endurance
+19 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: YogaExperimental Treatment1 Intervention
Participants receive online, group-based yoga classes 2 times/week for 60 minutes/class over 12 weeks.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Yoga
2008
Completed Phase 3
~3830

Find a Location

Who is running the clinical trial?

University of CalgaryLead Sponsor
792 Previous Clinical Trials
868,654 Total Patients Enrolled
Canadian Cancer Society (CCS)OTHER
78 Previous Clinical Trials
37,245 Total Patients Enrolled
Canadian Institutes of Health Research (CIHR)OTHER_GOV
1,344 Previous Clinical Trials
26,452,917 Total Patients Enrolled

Media Library

Yoga Clinical Trial Eligibility Overview. Trial Name: NCT05314803 — N/A
Cancer Research Study Groups: Yoga
Cancer Clinical Trial 2023: Yoga Highlights & Side Effects. Trial Name: NCT05314803 — N/A
Yoga 2023 Treatment Timeline for Medical Study. Trial Name: NCT05314803 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there open enrolment spots available in this research initiative?

"Yes, the trial is open for patient recruitment as per information posted on clinicaltrials.gov. This medical study was first made public on September 1st 2021 and its parameters were last revised in March 29th 2022."

Answered by AI

How many individuals have enrolled in this research trial?

"Correct. According to the records on clinicaltrials.gov, this medical study which was first published on September 1st 2021 is actively enrolling individuals. There are 500 patients being sought from a single location."

Answered by AI

Who else is applying?

What state do they live in?
Alberta
How old are they?
18 - 65
What portion of applicants met pre-screening criteria?
Did not meet criteria
Recent research and studies
~293 spots leftby Dec 2027